secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2026-06-04T12:00:40+00:00
Accession:  0001493152-26-027201
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IMUNON secures up to $10M through preferred stock and secured notes for Phase 3 trial
--------------------------------------------------------------------------------

- Gross proceeds of $10M from 250 Series A Preferred shares ($2.5M) and secured promissory notes ($7.72M total).
- Notes mature in 18 months; A-1 Note at 8% interest, B Note at 5%; secured by assets except IP.
- $5M placed in cash collateral; remaining $5M for general corporate purposes including Phase 3 OVATION 3 trial.
- Preferred stock is non-convertible, non-voting, 8% annual return; redeemable at 110% of liquidation amount.
- Financing structured as non-dilutive with no warrants; management highlights shareholder-friendly terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/0001493152-26-027201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315226027201/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer